Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 111


Regulation of inside-out β1-integrin activation by CDCP1.

Pollan SG, Huang F, Sperger JM, Lang JM, Morrissey C, Cress AE, Chu CY, Bhowmick NA, You S, Freeman MR, Spassov DS, Moasser MM, Carter WG, Satapathy SR, Shah K, Knudsen BS.

Oncogene. 2018 Mar 7. doi: 10.1038/s41388-018-0142-2. [Epub ahead of print]


Targeting the Cohesive Cluster Phenotype in Chordoma via β1 Integrin Increases Ionizing Radiation Efficacy.

Harryman WL, Gard JMC, Pond KW, Simpson SJ, Heppner LH, Hernandez-Cortes D, Little AS, Eschbacher JM, Cress AE.

Neoplasia. 2017 Nov;19(11):919-927. doi: 10.1016/j.neo.2017.08.005. Epub 2017 Sep 24.


The Cohesive Metastasis Phenotype in Human Prostate Cancer.

Harryman WL, Hinton JP, Rubenstein CP, Singh P, Nagle RB, Parker SJ, Knudsen BS, Cress AE.

Biochim Biophys Acta. 2016 Dec;1866(2):221-231. doi: 10.1016/j.bbcan.2016.09.005. Epub 2016 Sep 24. Review.


A basal cell defect promotes budding of prostatic intraepithelial neoplasia.

Wang M, Nagle RB, Knudsen BS, Rogers GC, Cress AE.

J Cell Sci. 2017 Jan 1;130(1):104-110. doi: 10.1242/jcs.188177. Epub 2016 Sep 8.


Characterization of Laminin Binding Integrin Internalization in Prostate Cancer Cells.

Das L, Anderson TA, Gard JM, Sroka IC, Strautman SR, Nagle RB, Morrissey C, Knudsen BS, Cress AE.

J Cell Biochem. 2017 May;118(5):1038-1049. doi: 10.1002/jcb.25673. Epub 2017 Jan 5.


Laminin-binding integrin gene copy number alterations in distinct epithelial-type cancers.

Harryman WL, Pond E, Singh P, Little AS, Eschbacher JM, Nagle RB, Cress AE.

Am J Transl Res. 2016 Feb 15;8(2):940-54. eCollection 2016.


Nuclear factor, erythroid 2-like 2-associated molecular signature predicts lung cancer survival.

Qian Z, Zhou T, Gurguis CI, Xu X, Wen Q, Lv J, Fang F, Hecker L, Cress AE, Natarajan V, Jacobson JR, Zhang DD, Garcia JG, Wang T.

Sci Rep. 2015 Nov 24;5:16889. doi: 10.1038/srep16889.


Role of Integrin β4 in Lung Endothelial Cell Inflammatory Responses to Mechanical Stress.

Chen W, Epshtein Y, Ni X, Dull RO, Cress AE, Garcia JG, Jacobson JR.

Sci Rep. 2015 Nov 17;5:16529. doi: 10.1038/srep16529.


ATP promotes cell survival via regulation of cytosolic [Ca2+] and Bcl-2/Bax ratio in lung cancer cells.

Song S, Jacobson KN, McDermott KM, Reddy SP, Cress AE, Tang H, Dudek SM, Black SM, Garcia JG, Makino A, Yuan JX.

Am J Physiol Cell Physiol. 2016 Jan 15;310(2):C99-114. doi: 10.1152/ajpcell.00092.2015. Epub 2015 Oct 21.


Schwann Cells Increase Prostate and Pancreatic Tumor Cell Invasion Using Laminin Binding A6 Integrin.

Sroka IC, Chopra H, Das L, Gard JM, Nagle RB, Cress AE.

J Cell Biochem. 2016 Feb;117(2):491-9. doi: 10.1002/jcb.25300.


Combined micro CT and histopathology for evaluation of skeletal metastasis in live animals.

Geffre CP, Pond E, Pond GD, Sroka IC, Gard JM, Skovan BA, Meek WE, Landowski TH, Nagle RB, Cress AE.

Am J Transl Res. 2015 Feb 15;7(2):348-55. eCollection 2015.


Gemcitabine resistant pancreatic cancer cell lines acquire an invasive phenotype with collateral hypersensitivity to histone deacetylase inhibitors.

Samulitis BK, Pond KW, Pond E, Cress AE, Patel H, Wisner L, Patel C, Dorr RT, Landowski TH.

Cancer Biol Ther. 2015;16(1):43-51. doi: 10.4161/15384047.2014.986967.


Intracellular modifiers of integrin alpha 6p production in aggressive prostate and breast cancer cell lines.

Kacsinta AD, Rubenstein CS, Sroka IC, Pawar S, Gard JM, Nagle RB, Cress AE.

Biochem Biophys Res Commun. 2014 Nov 14;454(2):335-40. doi: 10.1016/j.bbrc.2014.10.073. Epub 2014 Oct 22.


Targeting integrin α6 stimulates curative-type bone metastasis lesions in a xenograft model.

Landowski TH, Gard J, Pond E, Pond GD, Nagle RB, Geffre CP, Cress AE.

Mol Cancer Ther. 2014 Jun;13(6):1558-66. doi: 10.1158/1535-7163.MCT-13-0962. Epub 2014 Apr 16.


Inhibition of p38-MAPK signaling pathway attenuates breast cancer induced bone pain and disease progression in a murine model of cancer-induced bone pain.

Sukhtankar D, Okun A, Chandramouli A, Nelson MA, Vanderah TW, Cress AE, Porreca F, King T.

Mol Pain. 2011 Oct 20;7:81. doi: 10.1186/1744-8069-7-81.


Acquisition of resistance toward HYD1 correlates with a reduction in cleaved α4 integrin expression and a compromised CAM-DR phenotype.

Emmons MF, Gebhard AW, Nair RR, Baz R, McLaughlin ML, Cress AE, Hazlehurst LA.

Mol Cancer Ther. 2011 Dec;10(12):2257-66. doi: 10.1158/1535-7163.MCT-11-0149. Epub 2011 Oct 6.


Metastasis Update: Human Prostate Carcinoma Invasion via Tubulogenesis.

Nagle RB, Cress AE.

Prostate Cancer. 2011;2011:249290. doi: 10.1155/2011/249290. Epub 2011 Jun 21.


Macrophage-dependent cleavage of the laminin receptor α6β1 in prostate cancer.

Sroka IC, Sandoval CP, Chopra H, Gard JM, Pawar SC, Cress AE.

Mol Cancer Res. 2011 Oct;9(10):1319-28. doi: 10.1158/1541-7786.MCR-11-0080. Epub 2011 Aug 8.


The laminin binding integrin alpha6beta1 in prostate cancer perineural invasion.

Sroka IC, Anderson TA, McDaniel KM, Nagle RB, Gretzer MB, Cress AE.

J Cell Physiol. 2010 Aug;224(2):283-8. doi: 10.1002/jcp.22149. Review.


Role for DNA methylation in the regulation of miR-200c and miR-141 expression in normal and cancer cells.

Vrba L, Jensen TJ, Garbe JC, Heimark RL, Cress AE, Dickinson S, Stampfer MR, Futscher BW.

PLoS One. 2010 Jan 13;5(1):e8697. doi: 10.1371/journal.pone.0008697.


HYD1-induced increase in reactive oxygen species leads to autophagy and necrotic cell death in multiple myeloma cells.

Nair RR, Emmons MF, Cress AE, Argilagos RF, Lam K, Kerr WT, Wang HG, Dalton WS, Hazlehurst LA.

Mol Cancer Ther. 2009 Aug;8(8):2441-51. doi: 10.1158/1535-7163.MCT-09-0113. Epub 2009 Aug 11.


Transient dephosphorylation of p53 serine 376 as an early response to ionizing radiation.

Warters RL, Gaffney DK, Kramer GF, Martinez JD, Cress AE.

Radiat Res. 2009 Jun;171(6):725-34. doi: 10.1667/RR1576.1.


Extracellular engagement of alpha6 integrin inhibited urokinase-type plasminogen activator-mediated cleavage and delayed human prostate bone metastasis.

Ports MO, Nagle RB, Pond GD, Cress AE.

Cancer Res. 2009 Jun 15;69(12):5007-14. doi: 10.1158/0008-5472.CAN-09-0354. Epub 2009 Jun 2.


Human Cell Surface Receptors as Molecular Imaging Candidates for Metastatic Prostate Cancer.

Sroka IC, Pond GD, Nagle RB, Porreca F, King T, Pestano G, Futscher BW, Gard JM, Riley J, Cress AE.

Open Prost Cancer J. 2009 Jan 1;2:59-66.


The role of alpha 6 integrin in prostate cancer migration and bone pain in a novel xenograft model.

King TE, Pawar SC, Majuta L, Sroka IC, Wynn D, Demetriou MC, Nagle RB, Porreca F, Cress AE.

PLoS One. 2008;3(10):e3535. doi: 10.1371/journal.pone.0003535. Epub 2008 Oct 28.


Supporting the academic mission in an era of constrained resources: approaches at the University of Arizona College of Medicine.

Joiner KA, Libecap A, Cress AE, Wormsley S, St Germain P, Berg R, Malan P.

Acad Med. 2008 Sep;83(9):837-44. doi: 10.1097/ACM.0b013e318181d2b2.


Simplified purification procedure of laminin-332 and laminin-511 from human cell lines.

Sroka IC, Chen ML, Cress AE.

Biochem Biophys Res Commun. 2008 Oct 24;375(3):410-3. doi: 10.1016/j.bbrc.2008.08.029. Epub 2008 Aug 17.


Integrin A6 Cleavage in Mouse Skin Tumors.

Demetriou MC, Kwei KA, Powell MB, Nagle RB, Bowden GT, Cress AE.

Open Cancer J. 2008 Jan 1;2:1-4.


Spatially and temporally regulated alpha6 integrin cleavage during Xenopus laevis development.

Demetriou MC, Stylianou P, Andreou M, Yiannikouri O, Tsaprailis G, Cress AE, Skourides P.

Biochem Biophys Res Commun. 2008 Feb 15;366(3):779-85. Epub 2007 Dec 18.


alpha6 integrin cleavage: sensitizing human prostate cancer to ionizing radiation.

Pawar SC, Dougherty S, Pennington ME, Demetriou MC, Stea BD, Dorr RT, Cress AE.

Int J Radiat Biol. 2007 Nov-Dec;83(11-12):761-7.


Morphine treatment accelerates sarcoma-induced bone pain, bone loss, and spontaneous fracture in a murine model of bone cancer.

King T, Vardanyan A, Majuta L, Melemedjian O, Nagle R, Cress AE, Vanderah TW, Lai J, Porreca F.

Pain. 2007 Nov;132(1-2):154-68. Epub 2007 Aug 15.


Integrin alpha6 cleavage: a novel modification to modulate cell migration.

Pawar SC, Demetriou MC, Nagle RB, Bowden GT, Cress AE.

Exp Cell Res. 2007 Apr 1;313(6):1080-9. Epub 2007 Jan 17.


Tumor progression and metastasis from genetic to microenvironmental determinants: a workshop of the tumor progression and metastasis NIH study section in honor of Dr. Martin L. Padarathsingh, May 31, 2006, Georgetown, Washington, DC.

De Clerck YA, Weissman BE, Yu D, Parsons R, Bar-Eli M, Roy-Burman P, Seewaldt VL, Cress AE, Languino LR, Batra SK, Tang CK, Sheng S, Chen WT, Chellappan S, Cheng SY, Ladisch S, McCarthy JB, Coussens LM, Cohen MB.

Cancer Biol Ther. 2006 Dec;5(12):1588-99. Epub 2006 Dec 6. No abstract available.


The minimum element of a synthetic peptide required to block prostate tumor cell migration.

Sroka TC, Marik J, Pennington ME, Lam KS, Cress AE.

Cancer Biol Ther. 2006 Nov;5(11):1556-62. Epub 2006 Nov 30.


Synthetic D-amino acid peptide inhibits tumor cell motility on laminin-5.

Sroka TC, Pennington ME, Cress AE.

Carcinogenesis. 2006 Sep;27(9):1748-57. Epub 2006 Mar 14.


Epigenetic regulation of the cell type-specific gene 14-3-3sigma.

Oshiro MM, Futscher BW, Lisberg A, Wozniak RJ, Klimecki WT, Domann FE, Cress AE.

Neoplasia. 2005 Sep;7(9):799-808.


Epigenetic silencing of DSC3 is a common event in human breast cancer.

Oshiro MM, Kim CJ, Wozniak RJ, Junk DJ, Muñoz-Rodríguez JL, Burr JA, Fitzgerald M, Pawar SC, Cress AE, Domann FE, Futscher BW.

Breast Cancer Res. 2005;7(5):R669-80. Epub 2005 Jun 16.


Integrin-dependent amplification of the G2 arrest induced by ionizing radiation.

Kremer CL, Schmelz M, Cress AE.

Prostate. 2006 Jan 1;66(1):88-96.


Membrane type 1 matrix metalloprotease cleaves laminin-10 and promotes prostate cancer cell migration.

Bair EL, Chen ML, McDaniel K, Sekiguchi K, Cress AE, Nagle RB, Bowden GT.

Neoplasia. 2005 Apr;7(4):380-9.


Identification of a stem cell candidate in the normal human prostate gland.

Schmelz M, Moll R, Hesse U, Prasad AR, Gandolfi JA, Hasan SR, Bartholdi M, Cress AE.

Eur J Cell Biol. 2005 Mar;84(2-3):341-54.


Therapeutic targeting of prostate cancer.

Cress AE, Mohla S.

Cancer Biol Ther. 2004 Oct;3(10):1028-30. Epub 2004 Oct 15.


Extracellular alpha 6 integrin cleavage by urokinase-type plasminogen activator in human prostate cancer.

Demetriou MC, Pennington ME, Nagle RB, Cress AE.

Exp Cell Res. 2004 Apr 1;294(2):550-8.


Integrin clipping: a novel adhesion switch?

Demetriou MC, Cress AE.

J Cell Biochem. 2004 Jan 1;91(1):26-35. Review.


Androgen control of cell proliferation and cytoskeletal reorganization in human fibrosarcoma cells: role of RhoB signaling.

Chauhan S, Kunz S, Davis K, Roberts J, Martin G, Demetriou MC, Sroka TC, Cress AE, Miesfeld RL.

J Biol Chem. 2004 Jan 9;279(2):937-44. Epub 2003 Oct 23.


Androgen regulation of the human FERM domain encoding gene EHM2 in a cell model of steroid-induced differentiation.

Chauhan S, Pandey R, Way JF, Sroka TC, Demetriou MC, Kunz S, Cress AE, Mount DW, Miesfeld RL.

Biochem Biophys Res Commun. 2003 Oct 17;310(2):421-32.


Membrane type-1-matrix metalloproteinase expressed by prostate carcinoma cells cleaves human laminin-5 beta3 chain and induces cell migration.

Udayakumar TS, Chen ML, Bair EL, Von Bredow DC, Cress AE, Nagle RB, Bowden GT.

Cancer Res. 2003 May 1;63(9):2292-9.


Culturing precision-cut human prostate slices as an in vitro model of prostate pathobiology.

Parrish AR, Sallam K, Nyman DW, Orozco J, Cress AE, Dalkin BL, Nagle RB, Gandolfi AJ.

Cell Biol Toxicol. 2002;18(3):205-19.


Different phenotypes in human prostate cancer: alpha6 or alpha3 integrin in cell-extracellular adhesion sites.

Schmelz M, Cress AE, Scott KM, Bürger F, Cui H, Sallam K, McDaniel KM, Dalkin BL, Nagle RB.

Neoplasia. 2002 May-Jun;4(3):243-54.


Differential regulation of a novel variant of the alpha(6) integrin, alpha(6p).

Davis TL, Buerger F, Cress AE.

Cell Growth Differ. 2002 Mar;13(3):107-13.

Supplemental Content

Loading ...
Support Center